1-4 of 4
Jose Manuel Calvo-Villas, MD
Close
Sort by
Journal Articles

Intrathecal Liposomal Cytarabine (DepoCyte®) for Treatment of Leptomeningeal Involvement From Transformed (Richter's syndrome) and Non-Transformed B-Cell Chronic Lymphocytic Leukemia (B-CLL) in Spain: Report of 8 Cases.

Jose Manuel Calvo-Villas, MD, Jose Antonio Fernández, MD, Rosa Fernández, MD, Ignacio de la Fuente, MD, Ana Cristina Godoy, MD, Rodrigo Martino, MD, Maria del Carmen Mateos, MD, Concepción Poderos, MD
Journal: Blood
Blood (2009) 114 (22): 4411.
https://doi.org/10.1182/blood.V114.22.4411.4411
Published: 2009
Journal Articles

Efficacy of Lenalidomide-Based Regimens in Multiple Myeloma Complicated by Extramedullary Plasmacytomas at Relapse or Progression.

Jose Manuel Calvo-Villas, MD, Adrian Alegre, MD, Ricarda García-Sánchez, MD, Miguel T Hernández, MD, Pilar Giraldo, MD, Maite Zudaire, MD, Bremo Gusmao, MD, Juan N Rodríguez, MD, Carmen Calle, MD, Gemma Ramirez, MD, Belen Iñigo, MD, Joaquin Martinez, MD, Albert Oriol, MD
Journal: Blood
Blood (2009) 114 (22): 4952.
https://doi.org/10.1182/blood.V114.22.4952.4952
Published: 2009
Journal Articles

A Predictive Statistical Model To Identify Thalassemic Phenotype (β 0 vs β + ) in Heterozygous β-Thalassemia.

Jose Manuel Calvo-Villas, MD, Paloma Ropero, MD, Silvia De la Iglesia, MD, Maria Francisca Zapata, MD, Alejandro Mayosky, MD, Francisco Sicilia, MD
Journal: Blood
Blood (2007) 110 (11): 3823.
https://doi.org/10.1182/blood.V110.11.3823.3823
Published: 2007
Journal Articles

Serum Soluble Transferrin Receptor in Heterozygous β-Thalassaemia: Application in the Diagnosis of Iron Deficiency and as Hematologic Marker of Erythroid Activity According to Thalassaemic Genotypes (β 0 vs β + ).

Jose Manuel Calvo-Villas, MD, María Francisca Zapata, MD, Ivan Alvarez, MD, Silvia de la Iglesia, MD, Jorge Cuesta, MD, Elena Carreter, MD, Francisco Sicilia, MD
Journal: Blood
Blood (2006) 108 (11): 3828.
https://doi.org/10.1182/blood.V108.11.3828.3828
Published: 2006